Shareholder Information

Shares Issued

As at 7 January 2022, the number of shares in issue was 26,014,946. The company does not hold any ordinary shares in treasury.

Significant Shareholders

At 7 January 2022, the Company has been notified of the following interests in 3% or more of the issued ordinary share capital of the Company:

Shareholder	No. of ordinary shares	% of issued share capital
Invest Northern Ireland	3,197,865	12.29
Amati Global Investors Limited	2,341,463	9.00
Viridian Growth Fund LP	1,831,500	7.04
Octopus Investments Limited	1,525,258	5.86
Hargreave Hale Limited	1,402,439	5.39
Jim Johnston	1,317,325	5.06
Canaccord Genuity	1,268,865	4.88
Livingbridge VC LLP	1,219,512	4.69
Unicorn AIM VCT plc	1,219,512	4.69
Paul Warwick	1,030,363	3.98

Director Shareholdings

Director	No. of ordinary shares	% of issued share capital
Dr Richard John Buick	631,250	2.43
Dr Simon Gordon Douglas	255,800	0.98
Dr Alan Mawson ¹	124,000	0.48
Sonya Maria Ferguson	92,567	0.36
Timothy William Watts	27,575	0.11
Colin James Walsh ²	-	-
James Alexander Fair	-	-

(1) Alan Mawson is a non-executive director of Clarendon Fund Managers Limited ("Clarendon") and sits on Clarendon's investment committee. Clarendon is the fund manager for Nitech Growth Fund LP which holds 358,850 Ordinary Shares and Viridian Growth Fund LP which holds 1,831,500 Ordinary Shares.
(2) Colin Walsh is the Chief Executive and founder of Crescent Capital NI Limited, which is the fund manager for Crescent Capital III LP which holds 613,382 Ordinary Shares.